pe
pep-05322 v1 CC-BY-SA-4.0

Esculentin-1GRa cancer-fighting peptide

A lab-made peptide studied for its ability to kill cancer cells; experimental, not an approved drug.

statuscomputed targetANTICANCER length49 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.405
avg pLDDT61.6
ranking score0.574
STRUCTURE · PEP-05322 × ANTICANCER
ranking0.574
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence49 aa
15101520253035404549
GLFSKKG GKGGKSW IKGVFKG IKGIGKE VGGDVIR TGIEIAA CKIKGEC
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.5740687251091003 boltz-2
3-letter notation
Gly-Leu-Phe-Ser-Lys-Lys-Gly-Gly-Lys-Gly-Gly-Lys-Ser-Trp-Ile-Lys-Gly-Val-Phe-Lys-Gly-Ile-Lys-Gly-Ile-Gly-Lys-Glu-Val-Gly-Gly-Asp-Val-Ile-Arg-Thr-Gly-Ile-Glu-Ile-Ala-Ala-Cys-Lys-Ile-Lys-Gly-Glu-Cys
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Esculentin-1GRa cancer-fighting peptide (pep-05322, v1). PeptideModel. https://peptidemodel.com/card/pep-05322
@peptide{pep05322,
  sequence = {GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 1 papers
[1] source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use